“Everyone is keeping up with the Joneses, and there are more Joneses than ever.” This statement from art critic Jerry Saltz refers to the buying habits of a public hungry for trendy art. However, it could as easily apply to MRI technology, where the strength of the magnet—measured in units called Tesla, or T—makes all keep reading
The annual Genitourinary Cancers Symposium is a three day professional meeting on cancers related to the prostate, bladder, kidneys, and other organ systems related to urinary and sexual function. Prostate cancer has an entire poster section devoted just to this disease. At the Feb. 26-28, 2015 symposium on Orlando, one of the general presentation sessions keep reading
An international team of experts on imaging prostate cancer participated in a review of the literature on prostate MRI and active surveillance.[i] To give you an idea of how impressive the team was, here is a list of the institutions they represent: Erasmus University Medical Center (Depts. of Urology and Radiology), Rotterday, the Netherlands University keep reading
It seems intuitive, if not obvious, that superior imaging of the prostate gives precise information to guide a biopsy needle into a cancerous tumor. The typical ultrasound imaging used by urologists in their offices is inferior to magnetic resonance imaging (MRI). Ultrasound-guided transrectal (TRUS) biopsy has a minimum 35% chance of missing cancer. If our keep reading